FDA-Referenced Cagrilintide Peptide

?Sequence Accuracy?: 100% match to patent US20210137821A1, renal toxicity-free.
?Dosing Innovation?: C-terminal amidation extends t½ to 36h vs AOD9604's 12h.
?Ideal For?: Peptide replacement studies requiring patent clearance.
?Quality Proof?: MALDI-TOF sequencing ?99.2% in COA.

?Global Peptide Solutions Provider?
Specializing in GMP-certified peptide R&D, production & distribution for biomedical research and healthcare sectors.
?Core Competencies?
• ?End-to-End Expertise?: Molecular design to global cold chain logistics
• ?Scaled Capacity?: 100,000+ units/month in 10,000? ISO 13485 facility
• ?Quality Control?: 3-stage testing (HPLC/MS dual verification, >99% purity)
• ?Global Reach?: 50+ countries via US/EU/SG hubs with blockchain traceability
?Flagship Products?
? ?Weight Management?: Semaglutide, Tirzepatide, Cagrilintide
? ?Tissue Repair?: BPC-157 (multifunctional recovery)
? ?Next-Gen Solutions?: Antimicrobial & anti-aging peptides
?Operational Excellence?
? ?Stability?: 36-month validated shelf life at 25°C/60% RH
? ?Logistics?: GPS-tracked cold chain with DDP clearance (72hr dispatch)
? ?Compliance?: USP/EP standards & automated lyophilization
?Client Support?
• ?Shipping?: 5-9 business days via DHL/FedEx/Dedicated Line
• ?Payment?: Bank Transfer/Crypto/Alibaba Trade Assurance
• ?Guarantee?: Damaged/lost order replacement & real-time tracking

Telegram: @HelenTT
Whatsapp:+12139973355